DorfmanH.D., CzerniakB.Molecular biology of bone tumors. In: DorfmanH.D., CerniakB., eds. Bone Tumors.St Louis, Mo: Mosby Inc; 1998: 55–87.
2.
MiettinenM.Keratin subsets in spindle-cell sarcomas: keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol.1991; 138: 505–513.
3.
SwansonC., PerentesE., PhillipsL.Epithelial membrane antigen reactivity in mesenchymal neoplasms: an immunohistochemical study of 306 soft tissue sarcomas. Surg Pathol.1992; 2: 313–322.
4.
NakajimaT., KameyaT., WatanabeS.S-100 protein distribution in normal and neoplastic tissues. In: DeLellisR., ed. Advances in Immunohistochemistry.New York, NY: Mason; 1984: 141–158.
5.
GouldV.E., LeeI., WiedenmannB.Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Hum Pathol.1986; 17: 979–983.
6.
ArberD.A., WeissL.M.CD57: a review. Appl Immunohistochem.1995; 3: 137–152.
7.
LloydR.V., WarnerT.F.Immunohistochemistry of neuron specific enolase. In: DeLellisR.A., ed. Advances in Immunohistochemistry.New York, NY: Mason; 1984: 127–134.
8.
LongacreT.A., RouseR.V.CD31: a new marker for vascular neoplasia. Adv Anat Pathol.1994; 1: 16–20.
9.
MillardP.R., HeryetA.R.An immunohistological study of factor VIII-related antigen and Kaposi's sarcoma using polyclonal and monoclonal antibodies. J Pathol.1985; 146: 31–38.
10.
WeissL.M., ArberD.A., ChangK.L.CD68: a review. Appl Immunohistochem.1994; 2: 2–8.
11.
WeidnerN., TjoeJ.Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing ‘s sarcoma and peripheral neuroepithelioma. Am J Surg Pathol.1994; 18: 486–494.
12.
StevensonA.J., ChattenJ., BertoniF.CD99 (p30/32 MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience. Appl Immunohistochem.1994; 2: 231–240.
13.
FanburgJ.C., RosenbergA.E., WeaverD.L.Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma. Am J Clin Pathol.1997; 108(4): 464–473.
14.
O'ConnellJ.X., NanthakumarS.S., NielsenG.P.Osteoid osteoma: the uniquely innervated bone tumor. Mod Pathol.1998; 11(2): 175–180.
15.
KimJ., EllisG.L., MounsdonT.A.Usefulness of anticytokeratin immunoreactivity in osteosarcomas of the jaw. Oral Surg Oral Med Oral Pathol.1991; 72: 213–217.
16.
HasegawaT., KudoE., HizawaK.Immunophenotypic heterogeneity in osteosarcomas. Hum Pathol.1991; 22: 583–590.
17.
LoningT., LiebschJ., DellingG.Osteosarcomas and Ewing's sarcomas: comparative immunocytochemical investigation of filamentous proteins and cell membrane determinants. Virchows Arch A Pathol Anat Histopathol.1985; 407: 323–336.
18.
YamamuraH., YoshikawaH., TatsutaM.Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis. Int J Cancer.1998; 79: 245–250.
19.
AignerT., FrischholzS., DertingerS.Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias. Histochem Cell Biol.1997; 107: 435–440.
20.
DavisR.I., FosterH., BiggartD.J.C-erb B-2 staining in primary synovial chondromatosis: a comparison with other cartilaginous tumours. J Pathol.1996; 179: 392–395.
21.
BleiweissI.J., KleinM.J.Chondromyxoid fibroma: report of six cases with immunohistochemical studies. Mod Pathol.1990; 3: 664–666.
KempsonR.L., HendricksonM.R.An approach to diagnosis of soft tissue tumors. In: WeissS.W., BrooksJ.S.J., eds. Monographs in Pathology: Soft Tissue Tumors.Baltimore, Md: Williams & Wilkins; 1996: 1–36.
25.
TruongL.D., RangdaengS., CagleP.The diagnostic utility of desmin: a study of 584 cases and review of the literature. Am J Clin Pathol.1990; 93: 305–314.
26.
FranquemontD.W.Muscle-actin antibodies. Am J Clin Pathol.1993; 99: 353–356.
27.
DiasP., ParhamD.M., ShapiroD.N.Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res.1992; 52: 6431–6439.
28.
AntonescuC.R., ErlandsonR.A., HuvosA.G.Primary leiomyosarcoma of bone: a clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature review. Am J Surg Pathol.1997; 21: 1281–1294.
29.
HasegawaT., FujiiY., SekiK.Epithelioid angiosarcoma of bone. Hum Pathol.1997; 28: 985–989.
30.
Meis-KindblomJ.M., KindblomL.G.Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol.1998; 22: 683–697.
31.
KilpatrickS.E., KoplyayP.D., WardW.G.Epithelioid hemangioendothelioma of bone and soft tissue: a fine-needle aspiration biopsy study with histologic and immunohistochemical confirmation. Diagn Cytopathol.1998; 19: 38–43.
32.
ZhengM.H., FanY., SmithA.Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration. J Cell Biochem.1998; 70: 121–129.
33.
DoussisI.A., PuddleB., AthanasouN.A.Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue. J Clin Pathol.1992; 45: 398–404.
34.
FornasierV.L., ProtznerK., ZhangI.The prognostic significance of histomorphometry and immunohistochemistry in giant cell tumors of bone. Hum Pathol.1996; 27: 754–760.
35.
PanicoL., PasserettiU., De RosaN.Giant cell reparative granuloma of the distal skeletal bones: a report of five cases with immunohistochemical findings. Virchows Arch1994; 425: 315–320.
36.
MarunoM., YoshimineT., KuboT.A case of giant cell reparative granuloma of the petrous bone: demonstration of the proliferative component. Surg Neurol.1997; 48: 64–68.
37.
Llombart-BoschA., ContessoG., Peydro-OlayaA.Histology, immunohistochemistry, and electron microscopy of small round cell tumors of bone. Semin Diagn Pathol.1996; 13: 153–170.
38.
SorensenP.H., LiuX.F., DelattreO.Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol.1993; 2: 147–157.
39.
KovarH., DworzakM., StrehlS.Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene.1990; 5: 1067–1070.
40.
LeeC.S., SoutheyM.C., WatersK.EWS/FLI-1 fusion transcript detection and MIC2 immunohistochemical staining in the diagnosis of Ewing's sarcoma. Pediatr Pathol Lab Med.1996; 16: 379–392.
41.
LeeS.B., KolquistK.A., NicholsK.The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat Genet.1997; 17: 309–313.
42.
LawlorE.R., LimJ.F., TaoW.The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide. Cancer Res.1998; 58: 2469–2476.
43.
LawlorE.R., MathersJ.A., BainbridgeT.Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis. J Clin Oncol.1998; 16: 1150–1157.
O'HaraB.J., PaetauA., MiettinenM.Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol.1998; 29: 119–126.
46.
HazelbagH.M., Van den BroekL.J., FleurenG.J.Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation. Hum Pathol.1997; 28: 183–188.
